Apitoria Pharma Private Limited – FDA 483, Oct 25, 2019
Aurobindo Pharma Limited Unit VIII in Jinnaram Mandal, Telangana, was cited with four observations during an FDA inspection. The inspection revealed deficiencies in equipment cleaning validation, thoroughness of deviation investigations, Quality Unit procedures for stability testing of reprocessed batches, and completeness of batch production records. These issues indicate a lack of adequate controls and documentation in critical manufacturing processes.
ID · c0a8f710-466e-418e-9774-c7f4bef69156
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.